
2026-04-07
Kupulumuka kwa khansa ya chiwindi mu 2026 adawona kusintha kwakukulu chifukwa chakupambana kwamankhwala a neoadjuvant komanso malangizo osinthidwa azachipatala ochokera ku China. Kafukufuku waposachedwapa akusonyeza kuti mankhwala atsopano omwe amaperekedwa asanachite opaleshoni angathe kuwirikiza kawiri nthawi imene odwala amakhala popanda kuyambiranso, zomwe zingasinthe chisamaliro chapadziko lonse.
Malo a hepatocellular carcinoma (HCC) ndi chithandizo cha intrahepatic cholangiocarcinoma (ICC) chasintha kwambiri kumayambiriro kwa 2026. Kwa zaka makumi ambiri, khansa ya chiwindi imagwirizanitsidwa ndi kusauka bwino komanso kubwerezabwereza. Komabe, kupulumuka kwa khansa ya chiwindi ma metrics tsopano akufotokozedwanso ndi kuyesa kosamalitsa kochokera kuzipatala zazikulu zaku China.
Kafukufuku wofunikira kwambiri wofalitsidwa mu New England Journal of Medicine mu Marichi 2026 ikuwonetsa kusintha kwa paradigm. Motsogozedwa ndi ofufuza a pachipatala cha Zhongshan ku Fudan University, kuyesa kwapakati pazigawo zingapo kunawonetsa kuti njira inayake ya neoadjuvant imatha kukulitsa moyo wopanda zochitika zapakatikati kuchokera pa miyezi 8.7 mpaka miyezi 18. Izi zikuyimira kuwirikiza kawiri kwa nthawi yomwe odwala amakhala opanda khansa atalandira chithandizo.
Kufunika kwa deta iyi sikungathe kufotokozedwa mopambanitsa. Zakale, kupulumuka kwazaka zisanu pambuyo pa kuchitidwa opaleshoni kwa khansa zina za chiwindi kunali pakati pa 25% ndi 40%. Kuphatikizana kwa chithandizo chamankhwala ndi immunotherapy musanachite opaleshoni ikuyamba kukhala "chisamaliro" chatsopano kwa odwala oyenerera. Njira imeneyi imachepetsa zotupa kwambiri mpeni usanakhudze khungu, ndipo chiwopsezo cha mayankho amafika pafupifupi 55% m'magulu oyeserera.
Kupititsa patsogolo uku sikungochitika pazoyeserera zokha. Mu Januware 2026, National Health Commission of China idatulutsa Kuzindikira Khansa Yachiwindi Yoyambira ndi Malangizo Othandizira (2026 Edition). Chikalatachi chikuphatikiza umboni wapamwamba kwambiri, kuphatikiza kafukufuku wakale wapanyumba wofalitsidwa m'manyuzipepala apamwamba apadziko lonse lapansi, opereka chitsogozo chovomerezeka chaukadaulo pazachipatala m'dziko lonselo.
Kutulutsidwa kwa malangizo a 2026 ndi chizindikiro chofunikira kwambiri pankhondo yapadziko lonse lapansi yolimbana ndi khansa ya chiwindi. Mosiyana ndi zobwerezabwereza zam'mbuyomu, mtundu wa 2026 umaphatikizanso zomwe zapezeka munthawi ya "chitetezo cha chitetezo chamthupi". Zimapitilira kupitilira magawo osavuta achilengedwe kuphatikiza zinthu zomwe zingayambitse ngozi, kuwonetsetsa kuti chithandizo chikugwirizana ndi kuthekera kwa wodwala kuti abwererenso.
Chikalata chothandizira, the Kugwirizana kwa Katswiri pa Postoperative Adjuvant Therapy for Hepatocellular Carcinoma (Kusindikiza kwa 2026), idavumbulutsidwanso ku Shanghai. Motsogozedwa ndi akatswiri amaphunziro a Fan Jia ndi Zhou Jian, mgwirizanowu umakhudzanso nkhani yovuta ya kuyambiranso pambuyo pa opaleshoni, yomwe imakhudza 50% mpaka 70% ya odwala. Mgwirizanowu umapereka dongosolo lokhazikika lozindikiritsa odwala "omwe ali pachiwopsezo chapakatikati" omwe amapindula kwambiri ndi chithandizo cha adjuvant.
Mgwirizano wa 2026 umabweretsa njira yoyeretsedwa yogawa chiwopsezo chobwereza. stratification iyi ndiyofunikira kuti mudziwe ngati wodwala akufunika chithandizo chaukali kapena atha kuyang'aniridwa mwachizoloŵezi.
Kutsekera mwatsatanetsatane m'magulu "omwe ali pachiwopsezo chapakatikati" kumawonetsetsa kuti mankhwala amphamvu amasungidwa kwa omwe amawafuna kwambiri, kukulitsa kugawa kwazinthu ndikuchepetsa zotsatira zosafunikira kwa anthu omwe ali pachiwopsezo chochepa. Malangizowo akugogomezera kuti chithandizo chamankhwala chotsutsana ndi chotupa chalowa m'gawo latsopano pomwe kulemera kwake mumayendedwe a adjuvant kwawonjezeka kwambiri.
Lingaliro la chithandizo cha neoadjuvant-kuchiza khansa isanayambe kuchitidwa opaleshoni yoyamba-yamaliza maphunziro oyesera mpaka ofunika mu 2026. Chiyeso chodziwika bwino chokhudza odwala 178 m'zipatala za 11 ku China chinapereka umboni wamphamvu wofunikira kulimbitsa njira iyi.
Pakuyesaku, gulu limodzi lidalandira magawo atatu a Gemox chemotherapy kuphatikiza mankhwala omwe amawathandizira komanso othandizira a immunotherapy. Gulu lolamulira linachitidwa opaleshoni mwamsanga, yomwe inali chikhalidwe chachikhalidwe. Zotsatira zake zinali zomveka: kupulumuka kwapakatikati kwa gulu lophatikiza mankhwala osokoneza bongo kunali miyezi 18, poyerekeza ndi miyezi 8.7 yokha ya gulu la opaleshoni yokha.
Kupambana kwa malo odyerawa kuli pakuwukira kwake kosiyanasiyana pa chotupacho. Chemotherapy imapha mwachindunji ma cell omwe amagawikana mwachangu. Mankhwala ochizira omwe amayang'aniridwa amalepheretsa njira zina zomwe zimawonjezera kukula kwa chotupa ndi angiogenesis (kupanga zotengera zamagazi). Mankhwala a Immunotherapy, monga PD-1 inhibitors, amathandizira chitetezo cha mthupi kuzindikira ndikuukira maselo a khansa omwe mwina angapewe kuzindikirika.
Pochepetsa chotupacho musanachite opareshoni, madokotala ochita opaleshoni amatha kukwaniritsa malire omveka bwino (R0 resection), chomwe ndi chidziwitso chofunikira cha kupulumuka kwa nthawi yayitali. Kuphatikiza apo, kuchiza ma micrometastases koyambirira kumawalepheretsa kukhala ndi magawo ena a chiwindi kapena thupi panthawi ya opaleshoni.
Kayendedwe ka ntchito kameneka kakuvomerezedwa ndi zipatala zotsogola osati ku China kokha komanso kukhudza ma protocol padziko lonse lapansi. Kuthekera kosinthira milandu yosasinthika kukhala yosinthika kudzera pakutsitsa ndikofunika kwambiri kwa odwala omwe ali ndi zotupa zazikulu kapena zovuta.
Ngakhale atachitidwa opaleshoni yopambana, chiwopsezo chobwereranso chimakhalabe cholepheretsa chachikulu kwa nthawi yayitali kupulumuka kwa khansa ya chiwindi. The 2026 Expert Consensus imapereka malingaliro atsatanetsatane a chithandizo chothandizira, kuchoka panjira ya "mulingo umodzi wokwanira-onse" kupita kumankhwala olondola.
Mgwirizanowu ukuwonetsa kulowa kwa chithandizo chamankhwala mu "nthawi yolimbana ndi chitetezo chamthupi". Deta yochokera ku maphunziro okhudzana ndi sintilimab ndi atezolizumab kuphatikiza bevacizumab ("T + A" regimen) yawonjezera kulemera kwa chithandizo chamankhwala mu gawo la adjuvant.
Makamaka, monotherapy ya donafenib kwa odwala omwe ali pachiwopsezo chachikulu yawonetsa kuti chiwopsezo cha kuyambiranso kwa chaka chimodzi chikuyandikira 87%. M'magawo apadera a odwala, ma regimens ophatikizira adakankhira kupulumuka kwa chaka cha 1 ku 96.7%. Ziwerengerozi zikuyimira kudumphadumpha kwakukulu kuchokera ku mbiri yakale.
Kupatula mankhwala a systemic, chithandizo cham'deralo chimagwira ntchito yofunika kwambiri pakuchotsa matenda otsalira. Maupangiri a 2026 amaphatikiza ndikuwongolera zisonyezo za Transarterial Chemoembolization (TACE), Hepatic Arterial Infusion Chemotherapy (HAIC), ndi radiation therapy.
Zochita zokhazikikazi zimapangidwira kuti zigwirizane ndi bedi lachiwindi komwe kubwereza kumakhala kotheka, kumachita ngati chitetezo pamodzi ndi njira zochiritsira.
Njira ya Barcelona Clinic Liver Cancer (BCLC) ikadali yogwiritsidwa ntchito kwambiri padziko lonse lapansi. Kusintha kwa 2026 kumasunga magawo ake atatu oyambira, kuneneratu, ndi chithandizo koma kumabweretsa gawo losintha zisankho: chimango cha CUSE.
Kusintha kwa 2026 BCLC kumaphatikiza Kuvuta, Kusatsimikizika, Kugonjera, ndi Kutengeka (CUSE) popanga zisankho zachipatala. Izi zimavomereza kuti kuchiza khansa ya chiwindi sikungotsatira ndondomeko yotengera kukula kwa chotupa; kumaphatikizapo kufufuza zinthu zovuta zokhudzana ndi odwala.
Dongosololi limatsogolera magulu a Multidisciplinary Teams (MDT) kuti apange zisankho zambiri zasayansi, zokhudzana ndi odwala. Zimatsimikizira kuti chithandizo "chabwino" pamapepala chikugwirizana ndi zenizeni za moyo wa wodwalayo, makhalidwe ake, ndi malo osungiramo thupi.
| Gawo la BCLC | 2026 Zowonetsa Zosintha | Njira Zochiritsira Zoyambirira |
|---|---|---|
| Gawo 0 / A (Kumayambiriro Kwambiri / Koyambirira) | Kuphatikiza kwa Stereotactic Body Radiation Therapy (SBRT) ndi Transarterial Radioembolization (TARE) ngati njira zochizira. | Opaleshoni, Ablation, SBRT, TARE |
| Gawo B (Yapakatikati) | Umboni wamakono ndi wosakwanira kuthandizira kuphatikizika kwachizoloŵezi cha chithandizo chothandizira komanso chithandizo chamankhwala. | TACE, HAIC, Systemic Therapy (milandu yosankhidwa) |
| Gawo C (Zapamwamba) | Amaphatikiza ma immuno-combination regimens ngati mulingo woyamba wa chisamaliro. | Immune Checkpoint Inhibitors + TKIs / Antibodies |
| Gawo D (Pokwelera) | Ganizirani za chithandizo chabwino kwambiri chothandizira komanso kasamalidwe ka zizindikiro. | Palliative Care |
Kuphatikizika kwa SBRT ndi TARE ngati njira zochiritsira kwa odwala oyambilira kumakulitsa bokosi la zida kwa iwo omwe sakufuna kuchitidwa opaleshoni kapena kuchotsedwa chifukwa cha chotupa kapena comorbidities. Pakadali pano, chenjezo lokhudza kuphatikizika kwachizoloŵezi mu Gawo B likuwonetsa kudzipereka ku machitidwe ozikidwa pa umboni, kupeŵa kumwa mopitirira muyeso mpaka zambiri zitapezeka.
Mgwirizano wa 2026 umakhudzanso zochitika zapadera zomwe nthawi zambiri zimasokoneza kasamalidwe ka khansa ya chiwindi, makamaka kuyika chiwindi ndi chithandizo cha ablation.
Kwa odwala omwe akudwala chiwindi, kusankha kwa immunosuppressive regimen ndikofunikira. Mgwirizanowu umalimbikitsa kugwiritsa ntchito mTOR inhibitors (monga sirolimus kapena everolimus) monga msana wa immunosuppression. Mosiyana ndi ma calcineurin inhibitors, ma mTOR inhibitors adawonedwa kuti ali ndi anti-chotupa, zomwe zingathandize kuchepetsa chiopsezo cha khansa kuyambiranso pambuyo pa kumuika.
Ngakhale kuti umboni wapamwamba wa chithandizo cha adjuvant makamaka pambuyo pochotsa mimba udakalipobe, mgwirizanowu umanena kuti mankhwala omwe akuwongolera kapena immunotherapy akhoza kuganiziridwa kwa odwala omwe ali pachiopsezo chachikulu omwe akudwala. Popeza kuti ablation nthawi zambiri amagwiritsidwa ntchito pa zotupa zing'onozing'ono, chiopsezochi chimasiyana ndi kuchotsa kwakukulu, koma mfundo yothetsera matenda a micrometastatic imakhalabe yofunikira kwa iwo omwe ali ndi zovuta zowonongeka.
Mbali yofunika kwambiri, yomwe nthawi zambiri imanyalanyazidwa pakuwongolera kupulumuka kwa khansa ya chiwindi ndi chithandizo cha matenda a chiwindi. Malangizo a 2026 akugogomezera kuti chithandizo choyambirira chachiwindi ndichofunikira kwa odwala onse.
Kwa odwala omwe ali ndi khansa ya chiwindi yokhudzana ndi matenda a Hepatitis B Virus (HBV), kugwiritsa ntchito nucleoside analogs (monga tenofovir kapena entecavir) kwa moyo wonse ndikoyenera pambuyo pa opaleshoni. Kupondereza kubwereza kwa ma virus kumachepetsa kutupa, kumalepheretsa kuwonongeka kwa chiwindi, komanso kumachepetsa chiopsezo cha de novo carcinogenesis m'minyewa yotsala yachiwindi.
Kuphatikizana kodziwika kwamankhwala achikhalidwe ndi amakono, mgwirizano umalimbikitsa kugwiritsa ntchito Huaier granules pambuyo pa opaleshoni yoopsa. Zomwe azachipatala akuwonetsa zikuwonetsa kuti kukonzekera kwamankhwala amakono aku China kungathandize kuletsa kuyambiranso ndikukulitsa moyo wonse, ndikupereka chitetezo china kwa odwala omwe akuchira.
Njira zotsatirira zakonzedwanso, makamaka kwa magulu omwe ali ndi chiopsezo chapakati ndi chachikulu. Malangizowo ndi otsatiridwa osachepera miyezi itatu iliyonse. Kupitilira kujambula kwanthawi zonse (CT kapena MRI), malangizowo akuwonetsa kuti ngati mikhalidwe ingalole, umisiri wamadzimadzi a biopsy monga Circulating Tumor Cells (CTC) ndi circulating chotupa DNA (ctDNA) ziyenera kugwiritsidwa ntchito.
Kupeza chithandizo chapadera ndi chinthu chomwe chimatsimikizira zotsatira za kupulumuka. Odwala omwe akufuna njira zaposachedwa, kuphatikiza ma neoadjuvant regimens ndi njira zochiritsira zapamwamba zomwe zafotokozedwa pamwambapa, ayenera kuyang'ana malo omwe ali ndi dipatimenti yodzipereka ya hepatobiliary oncology.
Ku China, mabungwe monga Chipatala cha Zhongshan cha Fudan University, Chipatala cha Cancer cha Chinese Academy of Medical Science, ndi Chipatala Choyambirira Chogwirizana cha USTC ndi omwe akutsogolera pakukwaniritsa malangizowa a 2026. Padziko lonse lapansi, odwala ayenera kufunafuna malo a khansa osankhidwa ndi NCI kapena zipatala zaku yunivesite zomwe zili ndi mapulogalamu amphamvu a hepatobiliary.
Ngakhale kupita patsogolo kwachipatala mu 2026 kukulonjeza, mtengo ukadali wodetsa nkhawa kwambiri kwa odwala ambiri. Kusintha kwa kuphatikiza kwa immunotherapy ndi chithandizo chomwe mukuchiyang'anira kumatha kukulitsa zovuta zazachuma.
Ku China, mankhwala ambiri omwe akulimbikitsidwa, kuphatikiza zoletsa zapakhomo za PD-1 ndi TKIs, adaphatikizidwa m'buku la inshuwaransi yazachipatala ya dziko lonse, zomwe zikuchepetsa kwambiri ndalama zomwe odwala amawononga. Kusuntha kwa mfundozi ndikofunikira pakuwonetsetsa kuti "yankho ladziko" la kupewa ndi kuwongolera khansa ya chiwindi likupezeka kwa anthu ambiri.
Padziko lonse lapansi, kuperekedwa kumasiyanasiyana malinga ndi dziko komanso omwe amapereka inshuwaransi. Odwala amalimbikitsidwa kuti:
Ndikofunika kuyang'ana ndalama zothandizira chithandizo pazochitika za moyo wautali. Mankhwala othandiza a neoadjuvant ndi adjuvant omwe amaletsa kubwereza amatha kuchepetsa mtengo wonse wa chisamaliro popewa mankhwala opulumutsira okwera mtengo, kugonekedwa m'chipatala mobwerezabwereza, ndi chisamaliro chothandizira chokhudzana ndi matenda apamwamba, obwerezabwereza.
Ntchito yochiza khansa ya m'chiwindi ikupita patsogolo kwambiri. Maupangiri a 2026 ndi chithunzithunzi cha chidziwitso chamakono, koma kafukufuku akupitilira kukankhira malire. Zomwe zatumizidwa posachedwa ku Msonkhano Wapachaka wa 2026 wa ASCO kuchokera kumabungwe ngati Chipatala cha Zhongnan zikuwonetsa malire omwe akubwera.
Zatsopanozi zikusonyeza kuti tanthauzo la kupulumuka kwa khansa ya chiwindi apitiliza kuwongolera. Kuphatikizika kwa chidziwitso cha metabolic reprogramming ndi njira zama radiation zam'badwo wotsatira zimalonjeza kuthana ndi mitundu yolimbana ndi matendawa.
Chaka cha 2026 chikuwonetsa kusintha kwakukulu pankhondo yolimbana ndi khansa ya chiwindi. Ndi kufalitsidwa kwa malangizo osinthidwa a dziko, kutsimikiziridwa kwa mankhwala osakaniza a neoadjuvant, ndi kukonzanso kwa zitsanzo za chiopsezo cha stratification, odwala masiku ano ali ndi njira zothandiza kwambiri kuposa kale lonse. Kuchulukirachulukira kwa kupulumuka popanda zochitika m'mayesero aposachedwa kumapereka chiyembekezo chowoneka pomwe panali mwayi wochepa.
Kuchokera pakugwiritsa ntchito moyenera "omwe akuwongolera komanso chitetezo chamthupi" kupita ku kasamalidwe kotheratu kwa matenda a chiwindi, njira yopita patsogolo ikuwonekera. Kupambana kumadalira kuzindikira msanga, kupeza chithandizo chapadera chamagulu osiyanasiyana, ndikutsatira ndondomeko zamakono zozikidwa pa umboni. Pamene kafukufuku akupitilira kuwulula zovuta za biology ya khansa ya chiwindi, njira ya kupulumuka kwa khansa ya chiwindi amalozera m'mwamba pang'onopang'ono, kusintha matenda omwe anali oopsa kale kukhala matenda otha kutha, komanso ochiritsika.
Odwala ndi mabanja akulimbikitsidwa kuti azigwira ntchito limodzi ndi magulu awo azachipatala, kufunsa za malangizo aposachedwa, ndikuwunika njira zonse zochiritsira zomwe zilipo. Kulumikizana kwa ukatswiri wazachipatala waku China komanso mgwirizano wapadziko lonse wasayansi wapanga njira yolimba yogonjetsera khansa ya chiwindi, wodwala m'modzi panthawi.